China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Etanercept suppresses rheumatoid arthritis development via modulating miR-125a-3p'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131855
Registration Time: 2026/09/07
Type: Interventional study
Primary Sponsor: The Second Qilu Hospital of Shandong University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=316022
Published by HT Digital Content Services with permission from Health Daily Digest....